Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma-Reference-Cited by-同舟云学术

Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma

Published:2017-03-14 Issue:3 Volume:177 Page:457-466
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Shah Nina¹,Li Li¹,McCarty Jessica¹,Kaur Indreshpal¹,Yvon Eric¹,Shaim Hila¹,Muftuoglu Muharrem¹,Liu Enli¹,Orlowski Robert Z.²,Cooper Laurence³,Lee Dean⁴,Parmar Simrit¹,Cao Kai⁵,Sobieiski Catherine⁶,Saliba Rima¹,Hosing Chitra¹^ORCID,Ahmed Sairah¹,Nieto Yago¹,Bashir Qaiser¹,Patel Krina¹,Bollard Catherine⁷,Qazilbash Muzaffar¹,Champlin Richard¹,Rezvani Katy¹,Shpall Elizabeth J.¹

Affiliation:

1. Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA

2. Department of Lymphoma/Myeloma; University of Texas M.D. Anderson Cancer Center; Houston TX USA

3. Department of Pediatrics; University of Texas M.D. Anderson Cancer Center; Houston TX USA

4. Department of Hematology & Oncology; Nationwide Children's Hospital; Columbus OH USA

5. Department of Laboratory Medicine; University of Texas M.D. Anderson Cancer Center; Houston TX USA

6. Institute of Human Nutrition; Columbia University; College of Physicians and Surgeons; New York NY USA

7. Departments of Allergy and Immunology and Blood and Marrow Transplantation; Children's National Health System and George Washington University; Washington DC USA

Funder

Celgene

M.D. Anderson Cancer Center High Risk Multiple Myeloma Moon Shot

Stading-Younger Cancer Research Foundation

M.D. Anderson Molecular Evaluation and/or Biopsy Related Support Program

University of Texas MD Anderson Cancer Center

National Cancer Institute

Publisher

Wiley

Subject

Hematology

Link